{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:44:49Z","timestamp":1792759489614,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ijrobp.2024.02.025","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T07:27:35Z","timestamp":1709018855000},"page":"1545-1556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Understanding Relative Biological Effectiveness and Clinical Outcome of Prostate Cancer Therapy Using Particle Irradiation: Analysis of Tumor Control Probability With the Modified Microdosimetric Kinetic Model"],"prefix":"10.1016","volume":"119","author":[{"given":"Judith","family":"Besuglow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tessonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Mein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Eichkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mairani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.02.025_bib0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0002","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejmp.2016.03.017","article-title":"What can particle therapy add to the treatment of prostate cancer?","volume":"32","author":"Schwarz","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0003","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.zemedi.2021.11.003","article-title":"The history of ion beam therapy in Germany","volume":"32","author":"J\u00e4kel","year":"2022","journal-title":"Z F\u00fcr Med Phys"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0004","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1269\/jrr.10016","article-title":"Carbon ion radiotherapy: Clinical experiences at National Institute of Radiological Science (NIRS)","volume":"51","author":"Okada","year":"2010","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejmp.2015.03.002","article-title":"History of hadron therapy accelerators","volume":"31","author":"Degiovanni","year":"2015","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0006","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0360-3016(92)90058-P","article-title":"The proton treatment center at Loma Linda University Medical Center: Rationale for and description of its development","volume":"22","author":"Slater","year":"1992","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0007","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1088\/0031-9155\/57\/22\/7543","article-title":"Dose prescription in carbon ion radiotherapy: A planning study to compare NIRS and LEM approaches with a clinically-oriented strategy","volume":"57","author":"Fossati","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0008","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.radonc.2016.05.031","article-title":"Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems","volume":"120","author":"Molinelli","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0009","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cancers12010046","article-title":"Rectum dose constraints for carbon ion therapy: Relative biological effectiveness model dependence in relation to clinical outcomes","volume":"12","author":"Choi","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2003.10.011","article-title":"Proton therapy for prostate cancer: The initial Loma Linda University experience","volume":"59","author":"Slater","year":"2004","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0011","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2006.08.015","article-title":"Carbon ion radiation therapy for prostate cancer: Results of a prospective phase II study","volume":"81","author":"Ishikawa","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0012","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1118\/1.4939260","article-title":"A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy: TCP of prostate cancer treated EBRT","volume":"43","author":"Walsh","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0013","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aad9db","article-title":"Exploration and application of phenomenological RBE models for proton therapy","volume":"63","author":"R\u00f8rvik","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0014","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab2144","article-title":"Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer","volume":"64","author":"Marteinsdottir","year":"2019","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12885-020-6570-8","article-title":"Moderately hypofractionated carbon ion radiotherapy for prostate cancer: A prospective observational study \u201cGUNMA0702\u201d","volume":"20","author":"Kawamura","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-23-00002.1","article-title":"Case-matched outcomes of proton beam and intensity-modulated radiation therapy for localized prostate cancer","volume":"10","author":"Bao","year":"2023","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0017","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-2407-14-202","article-title":"Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique","volume":"14","author":"Habl","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0018","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijrobp.2016.02.025","article-title":"Acute toxicity and quality of life in patients with prostate cancer treated with protons or carbon ions in a prospective randomized Phase II study--The IPI trial","volume":"95","author":"Habl","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0019","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.radonc.2022.06.006","article-title":"Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and \u03b1\/\u03b2 = 2 Gy overestimates the RBE","volume":"173","author":"Eichkorn","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s004110050055","article-title":"Computation of cell survival in heavy ion beams for therapy","volume":"36","author":"Scholz","year":"1997","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0021","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ijrobp.2020.05.041","article-title":"Assessment of RBE-weighted dose models for carbon ion therapy toward modernization of clinical practice at HIT: In vitro, in Vivo, and in patients","volume":"108","author":"Mein","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0022","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2307\/3579114","article-title":"A statistical theory of cell killing by radiation of varying linear energy transfer","volume":"140","author":"Hawkins","year":"1994","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0023","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1088\/0031-9155\/55\/22\/008","article-title":"Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model","volume":"55","author":"Inaniwa","year":"2010","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0024","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1667\/RR3010","article-title":"A microdosimetric-kinetic model for the effect of non-Poisson distribution of lethal lesions on the variation of RBE with LET","volume":"160","author":"Hawkins","year":"2003","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0025","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1088\/0031-9155\/60\/8\/3271","article-title":"Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan","volume":"60","author":"Inaniwa","year":"2015","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0026","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-019-1295-z","article-title":"Biophysical modeling and experimental validation of relative biological effectiveness (RBE) for 4He ion beam therapy","volume":"14","author":"Mein","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0027","doi-asserted-by":"crossref","first-page":"N244","DOI":"10.1088\/1361-6560\/aa6be9","article-title":"Optimizing the modified microdosimetric kinetic model input parameters for proton and 4He ion beam therapy application","volume":"62","author":"Mairani","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0028","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1088\/1361-6560\/aa642b","article-title":"The FLUKA Monte Carlo code coupled with the NIRS approach for clinical dose calculations in carbon ion therapy","volume":"62","author":"Magro","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0029","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/iju.14950","article-title":"Carbon-ion radiotherapy for urological cancers","volume":"29","author":"Ishikawa","year":"2022","journal-title":"Int J Urol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: A review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"Van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0167-8140(02)00062-2","article-title":"Risk group dependence of dose\u2013response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer","volume":"63","author":"Levegr\u00fcn","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0032","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1012348","article-title":"Radiotherapy and short-term androgen deprivation for localized prostate cancer","volume":"365","author":"Jones","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0033","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijrobp.2021.08.031","article-title":"Adding short-term androgen deprivation therapy to radiation therapy in men with localized prostate cancer: Long-term update of the NRG\/RTOG 9408 randomized clinical trial","volume":"112","author":"Jones","year":"2022","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0034","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.2015.64.8055","article-title":"Short androgen suppression and radiation dose escalation for intermediate- and high-risk localized prostate cancer: Results of EORTC trial 22991","volume":"34","author":"Bolla","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0035","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: \u03b1\/\u03b2 = 1.4 (0.9\u20132.2) Gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0036","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/cam4.5045","article-title":"The clinical relative biological effectiveness and prostate-specific antigen kinetics of carbon-ion radiotherapy in low-risk prostate cancer","volume":"12","author":"Kang","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0037","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0360-3016(02)03828-2","article-title":"How low is the \u03b1\/\u03b2 ratio for prostate cancer?","volume":"55","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0038","unstructured":"A Ferrari, PR Sala, A Fass\u00f3, J Ranft, FLUKA: A multi-particle transport code. CERN-2005-10 (2005), INFN\/TC_05\/11, SLAC-R-773. Available at: http:\/\/www.slac.stanford.edu\/pubs\/slacreports\/reports16\/slac-r-773.pdf. Accessed March 20, 2024."},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0039","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nds.2014.07.049","article-title":"The FLUKA code: Developments and challenges for high energy and medical applications","volume":"120","author":"B\u00f6hlen","year":"2014","journal-title":"Nucl Data Sheets"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejmp.2020.11.028","article-title":"Rapid effective dose calculation for raster-scanning 4He ion therapy with the modified microdosimetric kinetic model (mMKM)","volume":"81","author":"Kopp","year":"2021","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0041","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1002\/mp.14417","article-title":"FRoG: An independent dose and LETd prediction tool for proton therapy at ProBeam\u00ae facilities","volume":"47","author":"Kopp","year":"2020","journal-title":"Med. Phys"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0042","doi-asserted-by":"crossref","first-page":"14829","DOI":"10.1038\/s41598-018-33194-4","article-title":"Fast robust dose calculation on GPU for high-precision 1H, 4He, 12C and 16O ion therapy: the FRoG platform","volume":"8","author":"Mein","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0043","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0360-3016(00)00568-X","article-title":"Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beams","volume":"48","author":"Suzuki","year":"2000","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0044","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(98)00544-6","article-title":"Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy","volume":"44","author":"Kanai","year":"1999","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0045","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ijrobp.2005.04.022","article-title":"Hypofractionated radiotherapy with carbon ion beams for prostate cancer","volume":"63","author":"Tsuji","year":"2005","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0046","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0047","doi-asserted-by":"crossref","first-page":"134","DOI":"10.6004\/jnccn.2021.0008","article-title":"NCCN Guidelines insights: Prostate cancer, version 1.2021: Featured updates to the NCCN guidelines","volume":"19","author":"Schaeffer","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0048","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0168-9002(93)91335-K","article-title":"Magnetic scanning system for heavy ion therapy","volume":"330","author":"Haberer","year":"1993","journal-title":"Nucl Instrum Methods Phys Res Sect Accel Spectrometers Detect Assoc Equip"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0049","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijrobp.2020.08.014","article-title":"Tumor control probability modeling and systematic review of the literature of stereotactic body radiation therapy for prostate cancer","volume":"110","author":"Royce","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0051","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1120\/jacmp.v5i1.1970","article-title":"A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets","volume":"5","author":"Warkentin","year":"2004","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0052","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09553009214552071","article-title":"Tumour and normal tissue responses to fractionated non-uniform dose delivery","volume":"62","author":"K\u00e4llman","year":"1992","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0053","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S1470-2045(14)70412-7","article-title":"Carbon ion radiotherapy in Japan: An assessment of 20 years of clinical experience","volume":"16","author":"Kamada","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0054","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2023.01.015","article-title":"Commissioning of helium ion therapy and the first patient treatment with active beam delivery","volume":"116","author":"Tessonnier","year":"2023","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0055","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2006.06.056","article-title":"Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer","volume":"66","author":"Ishikawa","year":"2006","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0056","doi-asserted-by":"crossref","first-page":"15TR02","DOI":"10.1088\/1361-6560\/ac65d3","article-title":"Roadmap: Helium ion therapy","volume":"67","author":"Mairani","year":"2022","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0057","doi-asserted-by":"crossref","first-page":"797354","DOI":"10.3389\/fphy.2021.797354","article-title":"The evolution of lateral dose distributions of helium Ion beams in air: From measurement and modeling to their impact on treatment planning","volume":"9","author":"Besuglow","year":"2022","journal-title":"Front Phys"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0058","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13014-018-1061-7","article-title":"Dose constraints in the rectum and bladder following carbon-ion radiotherapy for uterus carcinoma: A retrospective pooled analysis","volume":"13","author":"Okonogi","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.025_bib0059","first-page":"127","article-title":"Exploring breast and prostate cancer RNA-seq derived radiosensitivity with the Genomic Adjusted Radiation Dose (GARD) model","volume":"36","author":"Nolan","year":"2022","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624003316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624003316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T14:48:42Z","timestamp":1728917322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624003316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0360301624003316"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.02.025","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding Relative Biological Effectiveness and Clinical Outcome of Prostate Cancer Therapy Using Particle Irradiation: Analysis of Tumor Control Probability With the Modified Microdosimetric Kinetic Model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}